RTI, PierianDx Collaborate on Clinical Genomics Platform

Apr 17, 2018

|

NEW YORK (GenomeWeb) – RTI International and PierianDx today announced a strategic collaboration to accelerate the impact and adoption of PierianDx's genomics platform.

The collaboration includes an undisclosed investment and other strategic support to help advance PierianDx's growth plan, the firms said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

RTI, PierianDx Collaborate on Clinical Genomics Platform

To read the full story....

Breaking News

BioReference Settles False Claims, Kickback Allegations for $11.5M

Quest, Walmart Teaming Up to Deliver SARS-CoV-2 Home Sampling Kits Via Drone

UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug

Genosity Inks Comarketing Agreement with Personal Genome Diagnostics

What's Popular?

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

Illumina to Acquire Grail for $8B in Cash and Stock

Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark

FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Arna Genomics Raises $3.5M In Series A Financing

Sponsorships